Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓƵ articles
1
Pancreatic cancer halted by virus injection in three patients
2
The best new science-fiction books of June 2026
3
Does gravity create reality? A shocking path to a theory of everything
4
Glaciers in the 'roof of the world' have suddenly started melting
5
NASA plans a base on the moon spanning hundreds of square kilometres
6
Photons behave very strangely if you try to cut them
7
How a radical new view of life could reveal its origin – and aliens
8
Start-ups are racing to revolutionise mathematics with AI
9
Mathematical AI helps researchers crack 50-year-old problem
10
Q-Day could destroy bitcoin – and our retirement savings
